# clm_EB70297A6910

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_net_income  
value: 247,756,000 United States dollar  
valid_from: 2017-03-31  
valid_to: 2017-06-30  
published: 2017-04-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_DAC478AD397E  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly net income: 247,756,000 United States dollar", as of 2017-03-31 (until 2017-06-30). Claim clm_EB70297A6910, https://asof.is/claim/clm_EB70297A6910, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532017000030/0000875320-17-000030-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2017-04-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532017000030/0000875320-17-000030-index.htm (primary, SEC EDGAR 10-Q Q1 FY2017, published 2017-04-28)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_net_income | -38,841,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_EB70297A6910](/claim/clm_EB70297A6910.md) | [clm_E8FAE6590B2B](/claim/clm_E8FAE6590B2B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.